RxDoctor Payments Data

Daniel Guss, MD

Orthopaedic Surgery · Boston, MANPI 1043347479

Payments from drug & device makers

$11,049in general payments, 2019–2025

Across 12 payments — averaging $920.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • DJO, LLC$9K
  • Ossio Inc$2K
  • Novastep Inc.$414
  • Stryker$304
  • Medshape, Inc.$150
  • Carbofix Orthopedics Inc$93
  • plus $64 from 2 others
$7,197in research payments, 2019–2025

Across 1 payment — averaging $7197.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Butterfly Network, Inc.$7K

What the payments were for

  • Consulting fees$1,51614%
  • Grants$8,50877%
  • Food & beverage$1,0259%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
DJO, LLC1$8,508
Ossio Inc2$1,516
Novastep Inc.2$414
Stryker(2 entities)3$304
Medshape, Inc.1$150
Carbofix Orthopedics Inc1$93
Treace Medical Concepts, Inc.1$51
Kairos Surgical Inc1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,049 in reported general payments places this provider in the 70th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$132,847
Medicare patients
316
Services billed
753

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →